The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Amgen Inc

Nasdaq: AMGN
Last

(U.S.) $180.53

Today's change0.00 0.00%
Updated October 23 4:00 PM EDT. Delayed by at least 15 minutes.
 

Amgen Inc

Nasdaq: AMGN
Last

(U.S.) $180.53

Today's change0.00 0.00%
Updated October 23 4:00 PM EDT. Delayed by at least 15 minutes.

Amgen Inc closed at (U.S.)$180.53.

Shares have lost 0.75% over the last five days, but have gained 23.47% over the last year to date. This security has underperformed the S&P 500 by 5.90% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $180.53
  • High--
  • Low--
  • Bid / Ask(U.S.) $180.21 / (U.S.) $181.55
  • YTD % change+23.47%
  • Volume0
  • Average volume (10-day)2,567,648
  • Average volume (1-month)2,692,349
  • Average volume (3-month)2,786,338
  • 52-week range(U.S.) $133.64 to (U.S.) $191.10
  • Beta1.39
  • Trailing P/E16.42×
  • P/E 1 year forward14.35×
  • Forward PEG3.28×
  • Indicated annual dividend(U.S.) $4.60
  • Dividend yield2.55%
  • Trailing EPS(U.S.) $11.00
Updated October 23 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.00%Sector:HealthcareIndustry:Pharmaceuticals - Diversified

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue5,8105,4645,9655,811
Total other revenue--------
Total revenue5,8105,4645,9655,811
Gross profit4,7864,4684,8984,784
Total cost of revenue1,0249961,0671,027
Total operating expense3,1122,8733,4803,284
Selling / general / administrative1,2091,0641,3231,244
Research & development8737691,078990
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)7827-1110
Other operating expenses, total-721712323
Operating income2,6982,5912,4852,527
Interest income (expense), net non-operating-321-326-328-325
Gain (loss) on sale of assets--------
Other--------
Income before tax2,5422,4602,2832,418
Income after tax2,1512,0711,9352,017
Income tax, total391389348401
Net income2,1512,0711,9352,017
Total adjustments to net income--------
Net income before extra. items2,1512,0711,9352,017
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2,1512,0711,9352,017
Inc. avail. to common incl. extra. items2,1512,0711,9352,017
Diluted net income2,1512,0711,9352,017
Dilution adjustment--------
Diluted weighted average shares738741742753
Diluted EPS excluding extraordinary itemsvalue per share2.912.792.612.68
Dividends per sharevalue per share1.151.151.001.00
Diluted normalized EPSvalue per share3.002.832.482.68